Surface tethered epidermal growth factor protects proliferating and differentiating multipotential stromal cells from FasL-induced apoptosis

Stem Cells

Volumn 31, Issue 1, 2013, Pages 104-116

  Rodrigues, Melanie ^a   Blair, Harry ^a   Stockdale, Linda ^c   Griffith, Linda ^c   Wells, Alan ^a,b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Massachusetts Institute of Technology Cambridge   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adipocytes; Epidermal growth factor; Mesenchymal stem cells; Multipotential stromal cells; Osteoblasts

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FAS ANTIGEN; FAS LIGAND; OSTEOCALCIN; OXYGEN; TRANSCRIPTION FACTOR RUNX2;

ADIPOCYTE; ADIPOGENESIS; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; CELL HYPOXIA; CELL PROLIFERATION; CELL PROTECTION; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; INTERNALIZATION; MULTIPOTENT STEM CELL; OSTEOBLAST; PROTEIN EXPRESSION; SERUM;

ADIPOCYTES; APOPTOSIS; BIOCOMPATIBLE MATERIALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; FAS LIGAND PROTEIN; HUMANS; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84871600782     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1215     Document Type: Article

References (49)

1. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147. (Pubitemid 29282067)
2. Jones E, Yang X. Mesenchymal stem cells and bone regeneration: Current status. Injury 2011;42:562-568.
3. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-1084. (Pubitemid 44128350)
4. Caplan AI. Why are MSCs therapeutic? New data: New insight. J Pathol 2009;217:318-324.
5. Uccelli A, Prockop DJ. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr Opin Immunol 2010;22:768-774.
6. van der Bogt KE, Schrepfer S, Yu J et al. Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation 2009;87:642-652.
7. Rodrigues M, Griffith LG, Wells A. Growth factor regulation of proliferation and survival of multipotential stromal cells. Stem Cell Res Ther 2010;1:32.
8. Semont A, Mouiseddine M et al. Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis. Cell Death Differ 2010;17:952-961.
9. Zimmermann CE, Gierloff M et al. Survival of transplanted rat bone marrow-derived osteogenic stem cells in vivo. Tissue Eng Part A 2011;17:1147-1156.
10. Wei H, Li Z, Hu S et al. Apoptosis of mesenchymal stem cells induced by hydrogen peroxide concerns both endoplasmic reticulum stress and mitochondrial death pathway through regulation of caspases, p38 and JNK. J Cell Biochem 2010;111:967-978.
11. Zhu W, Chen J, Cong X et al. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 2006;24:416-425. (Pubitemid 44464811)
12. Kim WK, Meliton V, Bourquard Ne. Hedgehog signaling and osteogenic differentiation in multipotent bone marrow stromal cells are inhibited by oxidative stress. J Cell Biochem 2010;111:1199-1209.
13. Fan VH, Tamama K, Au A et al. Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells 2007;25:1241-1251. (Pubitemid 46684884)
14. Tamama K, Fan VH, Griffith LG et al. Epidermal growth factor as a candidate for ex vivo expansion of bone marrow-derived mesenchymal stem cells. Stem Cells 2006;24:686-695. (Pubitemid 44464773)
15. Rodrigues M, Turner O, Stolz D et al. Production of reactive oxygen species by multipoint stromal cells/mesenchymal stem cells upon exposure to FasL. Cell Transplant 2012 [Epub ahead of print].
16. Iyer AK, Tran KT, Borysenko CW et al. Tenascin cytotactin epidermal growth factor-like repeat binds epidermal growth factor receptor with low affinity. J Cell Physiol 2007;211:748-758. (Pubitemid 46683043)
17. Platt MO, Roman AJ, Wells A et al. Sustained epidermal growth factor receptor levels and activation by tethered ligand binding enhances osteogenic differentiation of multi-potent marrow stromal cells. J Cell Physiol 2009;221:306-317.
18. Gotherstrom C, Lundqvist A, Duprez IR et al. Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways. Cytotherapy 2011;13:269-278.
19. Liu Y, Wang L, Kikuiri T et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-gamma and TNF-alpha. Nat Med 2011;17:1594-1601.
20. Okamoto T, Aoyama T, Nakayama T et al. Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun 2002;295:354-361. (Pubitemid 34785842)
21. Wu S, Wells A, Griffith LG et al. Controlling multipotent stromal cell migration by integrating "course-graining" materials and "fine-tuning" small molecules via decision tree signal-response modeling. Biomaterials 2011;32:7524-7531.
22. Patterson TE, Kumagai K, Griffith L et al. Cellular strategies for enhancement of fracture repair. J Bone Joint Surg Am 2008;90(suppl 1):111-119. (Pubitemid 351329129)
23. Iwabu A, Smith K, Allen FD et al. Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway. J Biol Chem 2004;279:14551-14560. (Pubitemid 38618842)
24. Leloup L, Shao H, Bae YH. m-Calpain activation is regulated by its membrane localization and by its binding to phosphatidylinositol 4,5- bisphosphate. J Biol Chem 2010;285:33549-33566.
25. Shao H, Wu C, Wells A. Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin. J Biol Chem 2010;285:2591-2600.
26. Marcantonio NA, Boehm CA, Rozic RJ et al. The influence of tethered epidermal growth factor on connective tissue progenitor colony formation. Biomaterials 2009;30:4629-4638.
27. Tamama K, Kawasaki H, Wells A. Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. J Biomed Biotechnol 2010; 2010:795385.
28. Yamaza T, Miura Y, Bi Y et al. Pharmacologic stem cells based intervention as a new approach to osteoporosis treatment in rodents. PLoS One 2008;3:e2615.
29. Wells A, Welsh JB, Lazar CS et al. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science 1990; 247:962-964.
30. Haugh JM, Huang AC, Wiley HS et al. Internalized epidermal growth factor receptors participate in the activation of p21(ras) in fibroblasts. J Biol Chem 1999;274:34350-34360. (Pubitemid 129511778)
31. Wells A. Egf receptor. Int J Biochem Cell Biol 1999;31:637-643. (Pubitemid 29248872)
32. Chen P, Xie H, Wells A. Mitogenic signaling from the egf receptor is attenuated by a phospholipase C-gamma/protein kinase C feedback mechanism. Mol Biol Cell 1996;7:871-881. (Pubitemid 26181723)
33. Platt MO, Wilder CL, Wells A et al. Multipathway kinase signatures of multipotent stromal cells are predictive for osteogenic differentiation: Tissue-specific stem cells. Stem Cells 2009;27:2804-2814.
34. Kuhl PR, Griffith-Cima LG. Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase. Nat Med 1996;2:1022-1027. (Pubitemid 26306842)
35. Reddy CC, Wells A, Lauffenburger DA. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha. J Cell Physiol 1996;166:512-522. (Pubitemid 26095478)
36. Kratchmarova I, Blagoev B, Haack-Sorensen M et al. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 2005;308:1472-1477. (Pubitemid 40791302)
37. Nisoli E, Cardile A, Bulbarelli A et al. White adipocytes are less prone to apoptotic stimuli than brown adipocytes in rodent. Cell Death Differ 2006;13:2154-2156. (Pubitemid 44742699)
38. Park D, Spencer JA, Koh BI et al. Endogenous bone marrow MSCs are dynamic, fate restricted participants in bone maintenance and regeneration. Cell Stem Cell 2012;10:259-272.
39. Guan M, Yao W, Liu R et al. Directing mesenchymal stem cells to bone to augment formation and increase bone mass. Nat Med 2012; 18:456-62.
40. Fierro FA, Kalomoiris S, Sondergaard CS et al. Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy. Stem Cells 2011;29:1727-1737.
41. Takeshi I, Reiko T, Marchand S et al. Peroxisome proliferator-activated receptor c is required in mature white and brown adipocytes for their survival in the mouse. PNAS 2004;13:4534-4547.
42. Song IH, Caplan AI, Dennis JE. Dexamethasone inhibition of confluence-induced apoptosis in human mesenchymal stem cells. J Orthop Res 2009;27:216-221.
43. Song IH, Caplan AI, Dennis JE. In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo. J Orthop Res 2009;27:916-921.
44. Kuznetsov SA, Mankani MH, Robey PG. In vivo formation of bone and haematopoietic territories by transplanted human bone marrow stromal cells generated in medium with and without osteogenic supplements. J Tissue Eng Regen Med 2011. DOI: 10.1002/term.515.
45. Mankani MH, Kuznetsov SA, Robey PG. Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density. Exp Hematol 2007;35:995-1004.
46. Wong VW, Rustad KC, Glorzbach JP et al. Pullulan hydrogels improve mesenchymal stem cell delivery into high-oxidative-stress wounds. Macromol Biosci 2011;11:1458-1466.
47. Rustad KC, Wong VW, Sorkin M et al. Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold. Biomaterials 2012;33:80-90.
48. Hamrahi VF, Goverman J, Jung W et el. In vivo molecular imaging of murine embryonic stem cells delivered to a burn wound surface via IntegraVR scaffolding. J Burn Care Res 2012;33:e49-e54.
49. Wang F, Li Z, Tamama K et al. Fabrication and characterization of prosurvival growth factor releasing, anisotropic scaffolds for enhanced mesenchymal stem cell survival/growth and orientation. Biomacromolecules 2009;10:2609-2618.